Digital Health Transformation And Integrated Care Will Expand Reach

Published
18 Jul 24
Updated
06 Aug 25
AnalystConsensusTarget's Fair Value
US$80.07
18.2% undervalued intrinsic discount
06 Aug
US$65.51
Loading
1Y
17.4%
7D
3.3%

Author's Valuation

US$80.1

18.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Increased 4.81%

Shared on30 Apr 25
Fair value Decreased 0.78%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Increased 4.83%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 0.36%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 1.30%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Increased 0.11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 0.39%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Decreased 8.86%

AnalystConsensusTarget has increased revenue growth from 4.7% to 5.2% and increased future PE multiple from 12.6x to 13.9x.